Author(s): Haynes BF, Moody MA, Liao HX, Verkoczy L, Tomaras GD
The B cell arm of the immune response becomes activated soon after HIV-1 transmission, yet the initial antibody response does not control HIV-1 replication, and it takes months for neutralizing antibodies to develop against the autologous virus. Antibodies that can be broadly protective are made only in a minority of subjects and take years to develop—too late to affect the course of disease. New studies of the earliest stages of HIV-1 infection, new techniques to probe the human B cell repertoire, the modest degree of efficacy in a vaccine trial and new studies of human monoclonal antibodies that represent the types of immune responses an HIV-1 vaccine should induce are collectively illuminating paths that a successful HIV-1 vaccine might take.
Author(s): Barry SM, Mena Lora AJ, Novak RM
Author(s): Van Gils MJ, Sanders RW
Author(s): Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, et al.
Author(s): Julien JP, Cupo A, Sok D, Stanfield RL, Lyumkis D, et al.
Author(s): Lyumkis D, Julien JP, de Val N, Cupo A, Potter CS, et al.
Author(s): McBurney SP , Ross TM.
Author(s): Zhang Z, Li S, Gu Y, Xia N
Author(s): Berkhout B, Sanders RW
Author(s): Balazs AB, West AP
Author(s): Nguyen M, Huan-Tu G, Gonzalez-Edick M, Rivera VM, Clackson T, et al.
Author(s): Fang J, Yi S, Simmons A, Tu GH, Nguyen M, et al.
Author(s): Liu R, Paxton WA, Choe S, Ceradini D, Martin SR et al.
Author(s): Hütter G, Nowak D, Mossner M, Ganepola S, Müßig A, et al.
Author(s): Pace C, Markowitz M
Author(s): Dau B, Holodniy M.
Author(s): Barry SM, Lora AJM, Novak RM.
Author(s): Schiller J, Chackerian B
Author(s): US National library of Medicine
Author(s): US National library of Medicine
Author(s): US National library of Medicine
Author(s): Scharf L, Wang H, Gao H, Chen S, McDowall AW, et al.
Author(s): US National library of Medicine
Author(s): US National library of Medicine
Author(s): US National library of Medicine
Author(s): Zhang Z, Li S, Gu Y, Xia N
Author(s): Yang L, Wang P